» I do not care about this american university shit, but if you want to hear
» it, then uk is officialy leading country in cellular research currently.
» they do not have a president who vetoes important research
Well, you should, as its the US higher educational system that performs the vast amount of advanced research in the world. It is a far more robust system than any other nation’s, and it is far and away better funded. Look at the endowments of the top 15 US universities. There is more money there than most nation’s budgets (Harvard: 35 billion; Princeton: 17 billion; the next ten or so average 5 billion each, and that’s just the top 15).
And as for our FEDERAL program, that’s right, there’s no federal money for stem cell research. But, unlike the European research system, the US system has as much funding available privately (i.e., University funding) as it does publicly, which is a huge advantage. As mentioned by the other poster, there is actually much more stem cell research going on in the States than any other country, and its all being funded privately or through State grants.
I could explain why what I’ve written is true (I studied the issue in business school), but I don’t feel like conducting a seminar. The bottom line is, except for a few Asian nations (Japan, South Korea), the vast majority of 1st world, developed, technologically competent nations are, to some degree, socialistic in their policies, and this fact has a tremendous impact on the way capital flows to research. When you must depend on the State or the market (ie, going public like ITX had to), it hindereds the quality of tech research greatly. You must have a robust, private system of capital that does not require universiality of its applications (the State) or penalize for failure (the market) if you are to encourage pure, unmolested research. This can only be achieved through a healthy, wealthy intellectual source of capital (the university system).
The only chance we have for a cure is that a major US university gets behind the problem, followed by a major US corporation. It is the only way to get the necessary monitary and intellectual resources needed to actually produce a commercial product. That has happened with Follica, and it has the best shot of producing results.
ICX is destined to fail - I’m convinced of it since seeing Farjo’s posts and replies. But we’ll see in March.